no desc

Role of Gliclazide MR in T2D

Background Vimeo Live Event

About the event

In the realm of type 2 diabetes management, a singular goal stands out like a guiding star: mastering glycemic control.​

Keeping glycated hemoglobin under 7% should be a primary objective in the management of diabetic patients to ensure reduction of diabetes-related complications and improve their lifelong prognosis.​

Modern sulfonylureas (especially Gliclazide MR), have proven to do just this and are recommended in international guidelines due to their low adverse effects. Gliclazide MR offers glycemic control and long-term protection with a good tolerability profile and low risk of hypoglycemia. Find out how it does this by watching the full video: ​

SCAC 09/23 DM 548 SERVIER- For the exclusive use of health professionals

Background Vimeo Live Event

Don't miss our next events!

Subscribe to our newsletter to receive invitations to upcoming events

You can unsubscribe at any time by clicking on the link in our emails.
SERVIER CENTRAL AMERICA AND THE CARIBBEAN, S.A.Edificio Dream Plaza, Costa Del Este, Ciudad de Panamá, Panamá+507-301-0227Todo el contenido de este sitio web, es sólo para los profesionales de la salud y un uso interno del evento.
LogoCopyright © 2022 Servier University by SERVIER CENTRO AMÉRICA Y EL CARIBE, S.A.